RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
  AIDS
  Anthrax
  Dengue
  Ebola
  HCV
  Influenza
   H1N1
  Leishmaniasis
  Malaria
  MRSA
  Mumps
  Pertussis
  Prion Diseases
  SARS
  Shigella
  Small Pox
  Tuberculosis
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Proceedings of the National Academy of Sciences Influenza Channel

subscribe to Influenza newsletter
Latest Research : Infectious Diseases : Influenza

   EMAIL   |   PRINT
Bird flu vaccine may be fruitless

Feb 14, 2006 - 7:37:00 PM , Reviewed by: Priya Saxena
"The antigenic diversity of viruses currently circulating in South East Asia and southern China challenges the wisdom of reliance on a single human vaccine for pandemic preparedness."

 
[RxPG] A vaccine the British government ordered as a defence against avian flu may not be effective, latest scientific findings suggest.

GlaxoSmithKline is one of the companies developing such a vaccine named as generic H5N1 and it plans to enter clinical trials in April. It expects to be in production by the end of the year, and is marketing it to the British government, among others.

The British government has ordered two to three million doses of this vaccine and is soon to announce which company among those who tendered has been awarded the contract.

Researchers led by Yi Guan, of Shantou University, China, who studied the avian flu in China and South East Asia said that the diversity of the viruses are such that the vaccine may be fruitless, reported Times Online.

Bird flu has killed at least 88 people in Asia and Turkey since 2003, according to the World Health Organization. Birds carrying the virus have also been detected in Italy, Greece and Nigeria.

The researchers indicated that the virus has been spreading in an uncontrolled fashion in China for the past decade, has crossed into Vietnam on three occasions and may be spread by "carrier" poultry that show no symptoms.

The team in their research published in Proceedings of the National Academy of Sciences concludes: "The antigenic diversity of viruses currently circulating in South East Asia and southern China challenges the wisdom of reliance on a single human vaccine for pandemic preparedness."

The British government's other defence against the pandemic flu is the antiviral drug Tamiflu, of which it has ordered 14.6 million courses. A spokeswoman for the department of health said that almost five million had been delivered so far, the report said.



Publication: Indo-Asian News Service

Advertise in this space for $10 per month. Contact us today.


Related Influenza News
Genetic studies to explain the difference in susceptibility to the flu
Influenza predisposes to secondary bacterial infections
Closing schools for short periods does not decrease infection rates
Clinical trials of 2009 H1N1 influenza vaccines
Analysis of a critical protein produced by the 2009 H1N1 influenza A virus
Flu shot rates lag for adolescents at risk
Immune to avian flu?
Novel H3N1 Swine Influenza Virus Identified in Pigs in Korea
Are influenza vaccines worth the effort?
Oseltamivir significantly reduces the risk of death from influenza

Subscribe to Influenza Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)